Scott R. McKercher

Neuroscience · Life Sciences

48h-index12.4kcitations92works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neurogenesis and neuroplasticity mechanisms(10), Neuroscience and Neuropharmacology Research(9), Neuroinflammation and Neurodegeneration Mechanisms(8), Alzheimer's disease research and treatments(7), Pluripotent Stem Cells Research(7)

Publications92 total

Targeted protein S-nitrosylation of ACE2 inhibits SARS-CoV-2 infection
Nature Chemical Biology·2022· 33 citedOpen Access
Targeted protein S-nitrosylation of ACE2 as potential treatment to prevent spread of SARS-CoV-2 infection
2022· 3 citedOpen Access
Correction to: TCA cycle metabolic compromise due to an aberrant S‑nitrosoproteome in HIV‑associated neurocognitive disorder with methamphetamine use
Journal of NeuroVirology·2021Open Access
TCA cycle metabolic compromise due to an aberrant S-nitrosoproteome in HIV-associated neurocognitive disorder with methamphetamine use
Journal of NeuroVirology·2021· 12 citedOpen Access
Novel Therapeutic Approach for Excitatory/Inhibitory Imbalance in Neurodevelopmental and Neurodegenerative Diseases
The Annual Review of Pharmacology and Toxicology·2020· 79 cited
NitroSynapsin for the treatment of neurological manifestations of tuberous sclerosis complex in a rodent model
Neurobiology of Disease·2019· 13 citedOpen Access
NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism
Nature Communications·2017· 115 citedOpen Access
Molecular Pathway to Protection From Age-Dependent Photoreceptor Degeneration in <i>Mef2</i> Deficiency
Investigative Ophthalmology & Visual Science·2017· 17 citedOpen Access
MEF2D haploinsufficiency downregulates the NRF2 pathway and renders photoreceptors susceptible to light-induced oxidative stress
Proceedings of the National Academy of Sciences·2017· 50 citedOpen Access
Therapeutic advantage of pro-electrophilic drugs to activate the Nrf2/ARE pathway in Alzheimer’s disease models
Cell Death and Disease·2016· 87 citedOpen Access
Levetiracetam inhibits oligomeric Aβ-induced glutamate release from human astrocytes
Neuroreport·2016· 26 citedOpen Access
Correction: Corrigendum: Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease
Scientific Reports·2016· 4 citedOpen Access
Elevated glucose and oligomeric β-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation
Nature Communications·2016· 124 citedOpen Access
Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease
Scientific Reports·2015· 61 citedOpen Access
Differential Effects of Pharmacologic and Genetic Modulation of NMDA Receptor Activity on HIV/gp120-Induced Neuronal Damage in an In Vivo Mouse Model
Journal of Molecular Neuroscience·2015· 16 citedOpen Access
Nrf2 and HSF-1 Pathway Activation via Hydroquinone-Based Proelectrophilic Small Molecules Is Regulated by Electrochemical Oxidation Potential
ASN NEURO·2015· 21 citedOpen Access
Aberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseases
Neurobiology of Disease·2015· 157 citedOpen Access
Protection from cyanide‐induced brain injury by the Nrf2 transcriptional activator carnosic acid
Journal of Neurochemistry·2015· 61 citedOpen Access
Transcriptional profiling of MEF2-regulated genes in human neural progenitor cells derived from embryonic stem cells
Genomics Data·2014· 28 citedOpen Access
Leukemogenesis in Heterozygous<i>PU.1</i>Knockout Mice
Radiation Research·2014· 7 cited
page 1 of 5Next →

Frequent Co-authors

Stuart A. Lipton(24), Richard A. Maki(13), Tomohiro Nakamura(7), Nobuki Nakanishi(7), Rajesh Ambasudhan(7), Eliezer Masliah(7), Michael J. Klemsz(6), Maria Talantova(6), Sara Sanz‐Blasco(6), Shu‐ichi Okamoto(6), James Parker(6), Takumi Satoh(6), R. Maki(5), Antonio Celada(5), Mohd Waseem Akhtar(5), Jeffrey D. Zaremba(5), Gregory W. Henkel(4), M Klemsz(4), Charles Van Beveren(4), Shichun Tu(4)